USP <797> Revisions and Strategies

Join our panel as perspectives are shared on what the revisions mean, how changes impact patient care, and tips can be employed to help achieve compliance.


On the cUSP of Enforcement: USP <797> Revisions and Strategies


On the cUSP of Enforcement:  USP 797 Revisions and Strategies

Craig Greszler will moderate a panel of three distinguished panelists discussing the United States Pharmacopeia (USP) latest draft revisions to chapter <797> on 11/1/2022. This gives compounding entities a full year to adopt changes before they become official (expected 11/1/2023).


With only a few months remaining before regulators can enforce these changes, it is imperative that compounding entities across the nation develop a plan for complying. Join this panel of compounding experts as they share their perspectives on what the revisions mean, how changes impact patient care, and tips and tricks you may employ to help achieve compliance.  

Phil Ayers, PharmD, BCNSP, FMSHP, FASHP
Jamie Tharp, PharmD, BCSCP
Erika Anderson, CPhT, CSPT
Craig Greszler, PharmD, MBA, BCSP
Related Product


Thursday, August 29th at 12 pm ET / 9am PT

USP <797> Revisions and Strategies

Helpful Information
  • Identify the most important changes to USP <797> and how they impact the profession of pharmacy.
  • Define barriers to adopting standards and strategies to overcome those challenges.
  • Understand how technology can be leveraged to support USP chapter changes.


Chat with us
Our live chat is available between the hours of 8.30am - 5.00pm EST, Monday - Friday